BRPI0816785A2 - bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas - Google Patents
bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmasInfo
- Publication number
- BRPI0816785A2 BRPI0816785A2 BRPI0816785A BRPI0816785A BRPI0816785A2 BR PI0816785 A2 BRPI0816785 A2 BR PI0816785A2 BR PI0816785 A BRPI0816785 A BR PI0816785A BR PI0816785 A BRPI0816785 A BR PI0816785A BR PI0816785 A2 BRPI0816785 A2 BR PI0816785A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibody libraries
- synthetic antibody
- rationally designed
- designed synthetic
- rationally
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99378507P | 2007-09-14 | 2007-09-14 | |
| PCT/US2008/076300 WO2009036379A2 (en) | 2007-09-14 | 2008-09-12 | Rationally designed, synthetic antibody libraries and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0816785A2 true BRPI0816785A2 (pt) | 2017-05-02 |
Family
ID=40350153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0816785A BRPI0816785A2 (pt) | 2007-09-14 | 2008-09-12 | bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US8691730B2 (pt) |
| EP (3) | EP3753947A1 (pt) |
| JP (6) | JP5933894B2 (pt) |
| CN (1) | CN101855242B (pt) |
| AU (1) | AU2008298603B2 (pt) |
| BR (1) | BRPI0816785A2 (pt) |
| CA (3) | CA3187687A1 (pt) |
| DK (1) | DK3124497T3 (pt) |
| HK (1) | HK1147271A1 (pt) |
| MX (3) | MX344415B (pt) |
| WO (1) | WO2009036379A2 (pt) |
Families Citing this family (202)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004009618A2 (en) | 2002-07-18 | 2004-01-29 | Crucell Holland B.V. | Recombinant production of mixtures of antibodies |
| US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| DK2316940T3 (da) * | 2000-12-18 | 2013-11-04 | Dyax Corp | Fokuserede biblioteker af genpakker |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| EP1639009B1 (en) | 2003-05-30 | 2013-02-27 | Merus B.V. | Fab library for the preparation of a mixture of antibodies |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| US8877688B2 (en) * | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| MX344415B (es) | 2007-09-14 | 2016-12-15 | Adimab Inc | Bancos de anticuerpos sinteticos, designados racionalmente y usos para los mismos. |
| EP2098536A1 (en) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
| WO2009114815A1 (en) | 2008-03-13 | 2009-09-17 | Dyax Corp | Libraries of genetic packages comprising novel hc cdr3 designs |
| JP5780951B2 (ja) | 2008-04-24 | 2015-09-16 | ダイアックス コーポレーション | 新規のｈｃｃｄｒ１、ｃｄｒ２、およびｃｄｒ３設計、ならびに新規のｌｃｃｄｒ１、ｃｄｒ２、およびｃｄｒ３設計を含む、遺伝子パッケージのライブラリ |
| US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
| AU2010252939B2 (en) * | 2009-05-29 | 2014-06-26 | Morphosys Ag | A collection and methods for its use |
| JP2013504602A (ja) * | 2009-09-14 | 2013-02-07 | ダイアックス コーポレーション | 新しく設計したｈｃｃｄｒ３を含む遺伝子パッケージライブラリー |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| ES2603559T5 (es) | 2010-02-08 | 2021-02-22 | Regeneron Pharma | Cadena ligera común de ratón |
| WO2011100369A2 (en) * | 2010-02-09 | 2011-08-18 | The Trustees Of Columbia University In The City Of New York | Methods for altering polypeptide expression and solubility |
| CN105153307A (zh) * | 2010-05-04 | 2015-12-16 | 梅里麦克制药股份有限公司 | 抗表皮生长因子受体(egfr)的抗体及其用途 |
| WO2012009568A2 (en) * | 2010-07-16 | 2012-01-19 | Adimab, Llc | Antibody libraries |
| JP6253986B2 (ja) | 2010-11-19 | 2017-12-27 | モルフォシス・アーゲー | コレクション及びその使用方法 |
| DE102010056289A1 (de) * | 2010-12-24 | 2012-06-28 | Geneart Ag | Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken |
| US9260753B2 (en) | 2011-03-24 | 2016-02-16 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| ES2872081T3 (es) | 2011-08-05 | 2021-11-02 | Regeneron Pharma | Ratones con cadena ligera universal humanizada |
| CA2791109C (en) | 2011-09-26 | 2021-02-16 | Merus B.V. | Generation of binding molecules |
| US20140013456A1 (en) | 2012-03-16 | 2014-01-09 | Regeneron Pharmaceuticals, Inc. | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same |
| CA2865644A1 (en) | 2012-03-16 | 2013-09-19 | Regeneron Pharmaceuticals, Inc. | Mice that produce antigen-binding proteins with ph-dependent binding characteristics |
| PL2825037T4 (pl) | 2012-03-16 | 2020-03-31 | Regeneron Pharmaceuticals, Inc. | Gryzonie eksprymujące sekwencje immunoglobuliny wrażliwej na pH |
| KR102228296B1 (ko) | 2012-03-16 | 2021-03-17 | 리제너론 파마슈티칼스 인코포레이티드 | 히스티딘 공학처리된 경쇄 항체 및 그것을 생성하기 위한 유전자 변형된 비-사람 동물 |
| DK2668208T3 (en) | 2012-04-17 | 2015-08-31 | Arsanis Biosciences Gmbh | The cross-reactive antibody Staphylococcus Aureus |
| LT2838918T (lt) | 2012-04-20 | 2019-09-10 | Merus N.V. | Būdai ir priemonės heterodimerinių ig-tipo molekulių gamybai |
| SG11201408161RA (en) | 2012-06-08 | 2015-01-29 | Sutro Biopharma Inc | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| CN105120896B (zh) | 2013-01-17 | 2019-11-12 | 阿尔萨尼斯生物科学有限责任公司 | 多重抗药性大肠杆菌特异性抗体 |
| CA2899859C (en) | 2013-01-31 | 2022-08-16 | Codexis, Inc. | Methods, systems, and software for identifying biomolecules with interacting components |
| WO2014169076A1 (en) | 2013-04-09 | 2014-10-16 | Annexon,,Inc. | Methods of treatment for neuromyelitis optica |
| MX2015015965A (es) | 2013-05-21 | 2016-07-11 | Arsanis Biosciences Gmbh | Generacion de anticuerpos altamente potentes que neutralizan la toxina lukgh (lukab) de staphylococcus aureus. |
| CA2916521C (en) | 2013-07-09 | 2023-03-07 | Annexon, Inc. | Anti-complement factor c1q antibodies and uses thereof |
| ES2658039T3 (es) | 2013-07-10 | 2018-03-08 | Sutro Biopharma, Inc. | Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso |
| CN105873946A (zh) | 2013-10-17 | 2016-08-17 | 阿尔萨尼斯生物科学有限责任公司 | 交叉反应性金黄色葡萄球菌抗体序列 |
| JP6636498B2 (ja) | 2014-03-21 | 2020-01-29 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 単一ドメイン結合タンパク質を作る非ヒト動物 |
| US20170022291A1 (en) | 2014-04-01 | 2017-01-26 | Adimab, Llc | Multispecific antibody analogs comprising a common light chain, and methods of their preparation and use |
| MA39599A (fr) | 2014-05-14 | 2016-10-05 | Merrimack Pharmaceuticals Inc | Dosage et administration d'agents thérapeutiques anti-egfr |
| TWI695011B (zh) | 2014-06-18 | 2020-06-01 | 美商梅爾莎納醫療公司 | 抗ｈｅｒ２表位之單株抗體及其使用之方法 |
| AU2015289831B2 (en) | 2014-07-14 | 2021-01-28 | The Penn State Research Foundation | Compositions and methods for targeting of the surfactant protein a receptor |
| WO2016014725A1 (en) | 2014-07-22 | 2016-01-28 | The University Of Notre Dame Du Lac | Molecular constructs and uses thereof |
| EP3708227A1 (en) | 2014-07-22 | 2020-09-16 | Sutro Biopharma, Inc. | Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodies |
| EA201790342A1 (ru) | 2014-08-08 | 2017-07-31 | ЭЛЕКТОР ЭлЭлСи | Антитела к trem2 и способы их применения |
| JP2017532024A (ja) | 2014-09-09 | 2017-11-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | コンポジット単一細胞核酸分析のための液滴ベースの方法および機器 |
| MA40835A (fr) | 2014-10-23 | 2017-08-29 | Biogen Ma Inc | Anticorps anti-gpiib/iiia et leurs utilisations |
| MA40861A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Anticorps anti-glycoprotéines iib/iiia |
| EP3221361B1 (en) | 2014-11-19 | 2021-04-21 | Genentech, Inc. | Anti-transferrin receptor / anti-bace1 multispecific antibodies and methods of use |
| WO2016081639A1 (en) | 2014-11-19 | 2016-05-26 | Genentech, Inc. | Antibodies against bace1 and use thereof for neural disease immunotherapy |
| KR101694832B1 (ko) * | 2014-12-31 | 2017-01-12 | 앱클론(주) | 항체 라이브러리 및 그의 제작방법 |
| RU2021131224A (ru) | 2015-02-17 | 2021-11-03 | Х4 Фармасьютикалз (Австрия) ГмбХ | Антитела, нацеленные на о-антиген на основе галактана из k. pneumoniae |
| US11873483B2 (en) | 2015-03-11 | 2024-01-16 | The Broad Institute, Inc. | Proteomic analysis with nucleic acid identifiers |
| JP2018508224A (ja) | 2015-03-19 | 2018-03-29 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 抗原を結合する軽鎖可変領域を選択する非ヒト動物 |
| CA2981851A1 (en) | 2015-04-07 | 2016-10-13 | Alector Llc | Anti-sortilin antibodies and methods of use thereof |
| JP6962819B2 (ja) | 2015-04-10 | 2021-11-05 | アディマブ， エルエルシー | 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法 |
| EP3283514A1 (en) | 2015-04-17 | 2018-02-21 | ARSANIS Biosciences GmbH | Anti-staphylococcus aureus antibody combination preparation |
| WO2016177651A1 (en) * | 2015-05-01 | 2016-11-10 | Medimmune Limited | Novel phage display library, members thereof and uses of the same |
| WO2016201389A2 (en) | 2015-06-12 | 2016-12-15 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| WO2016201388A2 (en) | 2015-06-12 | 2016-12-15 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| JP2018525999A (ja) | 2015-08-28 | 2018-09-13 | アレクトル エルエルシー | 抗Ｓｉｇｌｅｃ−７抗体及びその使用方法 |
| TWI778943B (zh) | 2015-10-01 | 2022-10-01 | 美商潛能醫療有限公司 | 抗tigit抗原結合蛋白及其使用方法 |
| US20190330335A1 (en) | 2015-10-06 | 2019-10-31 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| BR112018007483A2 (pt) | 2015-10-16 | 2018-10-23 | Arsanis Biosciences Gmbh | ?anticorpo monoclonal bactericida contra klebsiella pneumoniae, uma preparação farmacêutica para uso médico e diagnóstico; ácido nucleico codificante; e método de produção? |
| US11092607B2 (en) | 2015-10-28 | 2021-08-17 | The Board Institute, Inc. | Multiplex analysis of single cell constituents |
| WO2017075297A1 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | High-throughput dynamic reagent delivery system |
| CA3003458A1 (en) | 2015-10-29 | 2017-05-04 | Alector Llc | Anti-siglec-9 antibodies and methods of use thereof |
| EP3377533A2 (en) | 2015-11-19 | 2018-09-26 | Sutro Biopharma, Inc. | Anti-lag3 antibodies, compositions comprising anti-lag3 antibodies and methods of making and using anti-lag3 antibodies |
| EP3405486A1 (en) * | 2016-01-19 | 2018-11-28 | Zumutor Biologics, Inc. | A method of generating a synthetic antibody library, said library and application(s) thereof |
| JOP20170013B1 (ar) | 2016-01-22 | 2021-08-17 | Merck Sharp & Dohme | أجسام xi مضادة لعامل مضاد للتجلط |
| KR20180104106A (ko) | 2016-01-27 | 2018-09-19 | 서트로 바이오파마, 인크. | anti-CD74 항체 접합체, anti-CD74 항체 접합체를 포함하는 조성물 및 anti-CD74 항체 접합체의 이용 방법 |
| US11472877B2 (en) | 2016-03-04 | 2022-10-18 | Alector Llc | Anti-TREM1 antibodies and methods of use thereof |
| KR20230152153A (ko) | 2016-03-10 | 2023-11-02 | 악셀레론 파마 인코포레이티드 | 액티빈 타입 2 수용체 결합 단백질 및 이의 용도 |
| CA3016474A1 (en) | 2016-03-15 | 2017-09-21 | Mersana Therapeutics, Inc. | Napi2b-targeted antibody-drug conjugates and methods of use thereof |
| KR102218714B1 (ko) | 2016-06-14 | 2021-02-24 | 머크 샤프 앤드 돔 코포레이션 | 항응고 인자 xi 항체 |
| WO2017218698A1 (en) | 2016-06-15 | 2017-12-21 | Sutro Biopharma, Inc. | Antibodies with engineered ch2 domains, compositions thereof and methods of using the same |
| US20190161534A1 (en) | 2016-08-12 | 2019-05-30 | Arsanis Biosciences Gmbh | Anti-galactan ii monoclonal antibodies targeting klebsiella pneumoniae |
| US10759848B2 (en) | 2016-08-12 | 2020-09-01 | Arsanis Biosciences Gmbh | Klebsiella pneumoniae O3 specific antibodies |
| EP3293293A1 (en) * | 2016-09-08 | 2018-03-14 | Italfarmaco SpA | Hc-cdr3-only libraries with reduced combinatorial redundancy and optimized loop length distribution |
| US20190233512A1 (en) | 2016-10-12 | 2019-08-01 | Sutro Biopharma, Inc. | Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodies |
| AR109621A1 (es) | 2016-10-24 | 2018-12-26 | Janssen Pharmaceuticals Inc | Formulaciones de vacunas contra glucoconjugados de expec |
| US10654929B2 (en) | 2016-11-02 | 2020-05-19 | Jounce Therapeutics, Inc. | Antibodies to PD-1 and uses thereof |
| JOP20190100A1 (ar) | 2016-11-19 | 2019-05-01 | Potenza Therapeutics Inc | بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها |
| CN110662770A (zh) | 2016-11-23 | 2020-01-07 | 比奥维拉迪维治疗股份有限公司 | 结合凝血因子ix和凝血因子x的双特异性抗体 |
| US20230139592A1 (en) | 2016-12-22 | 2023-05-04 | Wake Forest University Health Sciences | Sirp-gamma targeted agents for use in the treatment of cancer |
| RU2019123063A (ru) | 2016-12-23 | 2021-01-26 | Вистерра, Инк. | Связывающие полипептиды и способы их получения |
| JOP20190134A1 (ar) | 2016-12-23 | 2019-06-02 | Potenza Therapeutics Inc | بروتينات رابطة لمولد ضد مضادة لنيوروبيلين وطرق استخدامها |
| CN108239150A (zh) | 2016-12-24 | 2018-07-03 | 信达生物制药(苏州)有限公司 | 抗pcsk9抗体及其用途 |
| US20200095327A1 (en) * | 2017-02-08 | 2020-03-26 | Dragonfly Therapeutics, Inc. | Antibody heavy chain variable domains targeting the nkg2d receptor |
| AU2018219887A1 (en) | 2017-02-08 | 2019-08-22 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
| CA3235295A1 (en) | 2017-02-20 | 2018-08-23 | Dragonfly Therapeutics, Inc. | Proteins binding her2, nkg2d and cd16 |
| WO2018156777A1 (en) | 2017-02-22 | 2018-08-30 | Sutro Biopharma, Inc. | Pd-1/tim-3 bi-specific antibodies, compositions thereof, and methods of making and using the same |
| CN108623686A (zh) | 2017-03-25 | 2018-10-09 | 信达生物制药(苏州)有限公司 | 抗ox40抗体及其用途 |
| JOP20190203A1 (ar) | 2017-03-30 | 2019-09-03 | Potenza Therapeutics Inc | بروتينات رابطة لمولد ضد مضادة لـ tigit وطرق استخدامها |
| US11072816B2 (en) | 2017-05-03 | 2021-07-27 | The Broad Institute, Inc. | Single-cell proteomic assay using aptamers |
| EP3625258A1 (en) | 2017-05-16 | 2020-03-25 | Alector LLC | Anti-siglec-5 antibodies and methods of use thereof |
| EP3630292A2 (en) | 2017-05-24 | 2020-04-08 | Sutro Biopharma, Inc. | Pd-1/lag3 bi-specific antibodies, compositions thereof, and methods of making and using the same |
| CN111051344B (zh) | 2017-06-08 | 2023-10-27 | 黑带医疗有限公司 | Cd38调节抗体 |
| EP3635003A1 (en) | 2017-06-08 | 2020-04-15 | Black Belt Therapeutics Limited | Cd38 modulating antibody |
| CR20190593A (es) | 2017-06-22 | 2020-05-10 | Novartis Ag | Moléculas de anticuerpo que se unen a cd73 y usos de las mismas |
| JP7402521B2 (ja) | 2017-07-11 | 2023-12-21 | コンパス セラピューティクス リミテッド ライアビリティ カンパニー | ヒトｃｄ１３７に結合するアゴニスト性抗体およびその使用 |
| EP3658588A1 (en) | 2017-07-26 | 2020-06-03 | Sutro Biopharma, Inc. | Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphoma |
| PL3658589T3 (pl) | 2017-07-26 | 2024-03-18 | Forty Seven, Inc. | Przeciwciała anty-sirp-alfa i powiązane sposoby |
| CN110997720A (zh) | 2017-07-27 | 2020-04-10 | Iteos治疗公司 | 抗tigit抗体 |
| WO2019023504A1 (en) | 2017-07-27 | 2019-01-31 | Iteos Therapeutics Sa | ANTI-TIGIT ANTIBODIES |
| PT3601358T (pt) | 2017-08-03 | 2023-08-30 | Alector Llc | Anticorpos anti-trem2 e métodos de uso dos mesmos |
| CN110662765B (zh) | 2017-08-03 | 2023-09-29 | 艾利妥 | 抗cd33抗体及其使用方法 |
| JP7224338B2 (ja) | 2017-08-16 | 2023-02-17 | ブラック ベルト セラピューティクス リミテッド | Ｃｄ３８調節抗体 |
| EP3668543A1 (en) | 2017-08-16 | 2020-06-24 | Black Belt Therapeutics Limited | Cd38 antibody |
| JP7437301B2 (ja) | 2017-08-25 | 2024-02-22 | ファイヴ プライム セラピューティクス インク | Ｂ７－ｈ４抗体及びその使用方法 |
| CN109422811A (zh) | 2017-08-29 | 2019-03-05 | 信达生物制药(苏州)有限公司 | 抗cd47抗体及其用途 |
| SG11202002194UA (en) * | 2017-09-11 | 2020-04-29 | Twist Bioscience Corp | Gpcr binding proteins and synthesis thereof |
| US10596270B2 (en) | 2017-09-18 | 2020-03-24 | Sutro Biopharma, Inc. | Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates |
| EP3694545A4 (en) | 2017-10-11 | 2021-12-01 | Board Of Regents, The University Of Texas System | HUMAN PD-L1 ANTIBODIES AND METHOD OF USING THEM |
| WO2019089753A2 (en) | 2017-10-31 | 2019-05-09 | Compass Therapeutics Llc | Cd137 antibodies and pd-1 antagonists and uses thereof |
| WO2019099454A2 (en) * | 2017-11-15 | 2019-05-23 | Philippe Valadon | Highly functional antibody libraries |
| CN111712518A (zh) | 2017-11-17 | 2020-09-25 | 默沙东公司 | 对免疫球蛋白样转录物3(ilt3)具有特异性的抗体及其用途 |
| EP3713961A2 (en) | 2017-11-20 | 2020-09-30 | Compass Therapeutics LLC | Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof |
| AU2018371271A1 (en) | 2017-11-27 | 2020-06-11 | Purdue Pharma L.P. | Humanized antibodies targeting human tissue factor |
| WO2019129137A1 (zh) | 2017-12-27 | 2019-07-04 | 信达生物制药(苏州)有限公司 | 抗lag-3抗体及其用途 |
| CN109970856B (zh) | 2017-12-27 | 2022-08-23 | 信达生物制药(苏州)有限公司 | 抗lag-3抗体及其用途 |
| JP2021509823A (ja) | 2018-01-04 | 2021-04-08 | アイコニック セラピューティクス インコーポレイテッド | 抗組織因子抗体、抗体薬物コンジュゲート、及び関連する方法 |
| TWI800854B (zh) | 2018-02-01 | 2023-05-01 | 大陸商信達生物製藥（蘇州）有限公司 | 全人源的抗ｂ細胞成熟抗原（ｂｃｍａ）單鏈抗體及其應用 |
| PE20220278A1 (es) | 2018-02-08 | 2022-02-25 | Dragonfly Therapeutics Inc | Dominios variables de anticuerpos que se dirigen al receptor nkg2d |
| SG11202008105RA (en) | 2018-03-02 | 2020-09-29 | Five Prime Therapeutics Inc | B7-h4 antibodies and methods of use thereof |
| IL301295A (en) | 2018-03-14 | 2023-05-01 | Surface Oncology Inc | Antibodies that bind CD39 and uses thereof |
| SG11202008707YA (en) | 2018-03-22 | 2020-10-29 | Surface Oncology Inc | Anti-il-27 antibodies and uses thereof |
| EP3768726A4 (en) | 2018-03-23 | 2021-12-22 | Board of Regents, The University of Texas System | DOUBLE SPECIFICITY ANTIBODIES FOR PD-L1 AND PD-L2 AND METHOD OF USING THEREOF |
| EP3774901A1 (en) | 2018-03-26 | 2021-02-17 | Sutro Biopharma, Inc. | Anti-bcma receptor antibodies, compositions comprising anti bcma receptor antibodies and methods of making and using anti-bcma antibodies |
| CN110464842B (zh) | 2018-05-11 | 2022-10-14 | 信达生物制药(苏州)有限公司 | 包含抗pcsk9抗体的制剂及其用途 |
| JP2021524451A (ja) * | 2018-05-18 | 2021-09-13 | マクロジェニクス，インコーポレーテッド | 最適化済みｇｐ４１結合分子及びその使用 |
| WO2019226973A1 (en) | 2018-05-25 | 2019-11-28 | Alector Llc | Anti-sirpa antibodies and methods of use thereof |
| WO2019232244A2 (en) | 2018-05-31 | 2019-12-05 | Novartis Ag | Antibody molecules to cd73 and uses thereof |
| KR102115300B1 (ko) * | 2018-06-01 | 2020-05-26 | 재단법인 목암생명과학연구소 | 항체 라이브러리 및 이를 이용한 항체 스크리닝 방법 |
| EP3814376A4 (en) | 2018-06-26 | 2022-07-06 | Mor Research Applications Ltd. | ANTI-TRANSTHYRETIN ANTIBODIES AND THEIR USES |
| CN112384532A (zh) | 2018-06-29 | 2021-02-19 | 艾利妥 | 抗SIRP-β1抗体及其使用方法 |
| CA3106115A1 (en) | 2018-07-08 | 2020-01-16 | Specifica Inc. | Antibody libraries with maximized antibody developability characteristics |
| AU2019246837B2 (en) | 2018-07-13 | 2024-03-21 | Alector Llc | Anti-Sortilin antibodies and methods of use thereof |
| AU2019306628A1 (en) | 2018-07-20 | 2021-02-11 | Surface Oncology, Inc. | Anti-CD112R compositions and methods |
| TWI754157B (zh) | 2018-07-25 | 2022-02-01 | 大陸商信達生物製藥（蘇州）有限公司 | 抗ｔｉｇｉｔ抗體及其用途 |
| CN112752768A (zh) | 2018-07-27 | 2021-05-04 | 艾利妥 | 抗siglec-5抗体及其使用方法 |
| WO2020033923A1 (en) | 2018-08-09 | 2020-02-13 | Compass Therapeutics Llc | Antigen binding agents that bind cd277 and uses thereof |
| WO2020033925A2 (en) | 2018-08-09 | 2020-02-13 | Compass Therapeutics Llc | Antibodies that bind cd277 and uses thereof |
| WO2020033926A2 (en) | 2018-08-09 | 2020-02-13 | Compass Therapeutics Llc | Antibodies that bind cd277 and uses thereof |
| MX2021002002A (es) | 2018-08-23 | 2021-05-31 | Seagen Inc | Anticuerpos anti inmunorreceptor de celulas t con dominios ig y motivo inhibidor inmunorreceptor basado en tirosina (tigit). |
| JP2022500454A (ja) | 2018-09-17 | 2022-01-04 | ストロ バイオファーマ インコーポレーテッド | 抗葉酸受容体抗体コンジュゲートによる併用療法 |
| EA202190609A1 (ru) | 2018-09-27 | 2021-08-17 | Тизона Терапьютикс | Антитела против hla-g, композиции, содержащие антитела против hla-g, и способы применения антител против hla-g |
| US11046769B2 (en) | 2018-11-13 | 2021-06-29 | Compass Therapeutics Llc | Multispecific binding constructs against checkpoint molecules and uses thereof |
| BR112021013397A2 (pt) | 2019-01-07 | 2021-12-07 | iTeos Belgium SA | Anticorpos anti-tigit |
| EP3911679A1 (en) | 2019-01-16 | 2021-11-24 | Compass Therapeutics LLC | Formulations of antibodies that bind human cd137 and uses thereof |
| US20230242660A1 (en) | 2019-02-21 | 2023-08-03 | Trishula Therapeutics, Inc. | Combination therapy involving anti-cd39 antibodies and anti-pd-1 or anti-pd-l1 antibodies |
| AU2020227802A1 (en) * | 2019-02-26 | 2021-10-14 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
| PE20212265A1 (es) | 2019-03-18 | 2021-11-30 | Janssen Pharmaceuticals Inc | Bioconjugados de antigenos-polisacaridos de e. coli, metodos de produccion y metodos de utilizacion de los mismos |
| WO2020210358A1 (en) | 2019-04-08 | 2020-10-15 | Biogen Ma Inc. | Anti-integrin antibodies and uses thereof |
| AU2020270407A1 (en) | 2019-05-03 | 2021-12-02 | Celgene Corporation | Anti-BCMA antibody conjugate, compositions comprising the same, and methods of making and using the same |
| US20220362394A1 (en) | 2019-05-03 | 2022-11-17 | Sutro Biopharma, Inc. | Anti-bcma antibody conjugates |
| WO2020252043A1 (en) | 2019-06-10 | 2020-12-17 | Sutro Biopharma, Inc. | 5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF |
| EP3983410A1 (en) | 2019-06-17 | 2022-04-20 | Sutro Biopharma, Inc. | 1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis |
| WO2021055329A1 (en) | 2019-09-16 | 2021-03-25 | Surface Oncology, Inc. | Anti-cd39 antibody compositions and methods |
| US20210115127A1 (en) | 2019-09-25 | 2021-04-22 | Surface Oncology, Inc. | Anti-il-27 antibodies and uses thereof |
| US11459389B2 (en) | 2019-10-24 | 2022-10-04 | Massachusetts Institute Of Technology | Monoclonal antibodies that bind human CD161 |
| CA3158565A1 (en) | 2019-12-05 | 2021-06-10 | Tina SCHWABE | Methods of use of anti-trem2 antibodies |
| JP2023506014A (ja) | 2019-12-12 | 2023-02-14 | アレクトル エルエルシー | 抗ｃｄ３３抗体の使用方法 |
| WO2021115468A1 (zh) * | 2019-12-13 | 2021-06-17 | 南京金斯瑞生物科技有限公司 | 一种构建抗体互补决定区文库的方法 |
| JP2023509083A (ja) | 2020-01-09 | 2023-03-06 | イノベント バイオロジクス（スーチョウ）カンパニー，リミティド | 腫瘍を予防又は治療するための薬物の調製における抗ｃｄ４７抗体と抗ｃｄ２０抗体の組み合わせの使用 |
| CN111139264B (zh) * | 2020-01-20 | 2021-07-06 | 天津达济科技有限公司 | 一种基于线性双链dna分子在哺乳动物细胞系内构建单域抗体库的方法 |
| BR112022016368A2 (pt) | 2020-02-18 | 2023-01-10 | Alector Llc | Anticorpos pilra e seus métodos de uso |
| US20230159637A1 (en) | 2020-02-24 | 2023-05-25 | Alector Llc | Methods of use of anti-trem2 antibodies |
| CN115515632A (zh) * | 2020-02-28 | 2022-12-23 | 布里格姆妇女医院 | 通过多特异性抗体选择性调节转化生长因子β超家族信号传导 |
| JP2023519584A (ja) | 2020-03-23 | 2023-05-11 | バイオ － テラ ソリューションズ、リミテッド | 免疫細胞活性化剤の開発及び応用 |
| US20230183341A1 (en) | 2020-04-03 | 2023-06-15 | Alector Llc | Methods of use of anti-trem2 antibodies |
| WO2021217024A1 (en) | 2020-04-24 | 2021-10-28 | Millennium Pharmaceuticals, Inc. | Anti-cd19 antibodies and uses thereof |
| MX2022014422A (es) | 2020-05-17 | 2022-12-07 | Astrazeneca Uk Ltd | Anticuerpos contra el sars-cov-2 y metodos de seleccion y uso de los mismos. |
| WO2021262765A1 (en) | 2020-06-22 | 2021-12-30 | The Board Of Trustees Of The Leland Stanford Junior University | Tsp-1 inhibitors for the treatment of aged, atrophied or dystrophied muscle |
| EP4169948A1 (en) | 2020-06-22 | 2023-04-26 | Innovent Biologics (Suzhou) Co., Ltd. | Anti-cd73 antibody and use thereof |
| US20230279078A1 (en) | 2020-07-20 | 2023-09-07 | Astrazeneca Uk Limited | Sars-cov-2 proteins, anti-sars-cov-2 antibodies, and methods of using the same |
| WO2022040345A1 (en) | 2020-08-18 | 2022-02-24 | Cephalon, Inc. | Anti-par-2 antibodies and methods of use thereof |
| IL302402A (en) | 2020-11-08 | 2023-06-01 | Seagen Inc | Combined treatment |
| KR20230128290A (ko) * | 2020-12-03 | 2023-09-04 | 타보텍 바이오테라퓨틱스 (홍콩) 리미티드 | 가변 중쇄 전용 라이브러리, 이의 제조 방법, 및 이의용도 |
| CN116744970A (zh) | 2020-12-11 | 2023-09-12 | 北卡罗来纳大学教堂山分校 | 包含sfrp2拮抗剂的组合物和方法 |
| JP2024505049A (ja) | 2021-01-29 | 2024-02-02 | ノバルティス アーゲー | 抗ｃｄ７３及び抗ｅｎｔｐｄ２抗体のための投与方式並びにその使用 |
| CA3216170A1 (en) | 2021-04-09 | 2022-10-13 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
| KR20240004659A (ko) | 2021-04-30 | 2024-01-11 | 셀진 코포레이션 | 감마 세크레타제 억제제(gsi)와 병용하여 항-bcma 항체-약물 접합체(adc)를 사용하는 병용 요법 |
| EP4340876A1 (en) | 2021-05-19 | 2024-03-27 | Sutro Biopharma, Inc. | Anti-folate receptor conjugate combination therapy with bevacizumab |
| CN113668068A (zh) * | 2021-07-20 | 2021-11-19 | 广州滴纳生物科技有限公司 | 基因组甲基化文库及其制备方法和应用 |
| KR20240043786A (ko) | 2021-08-09 | 2024-04-03 | 바이오세우스 인크. | 항-tigit 항체 및 이의 용도 |
| IL310535A (en) | 2021-08-10 | 2024-03-01 | Byomass Inc | Anti-GDF15 antibodies, compositions and uses thereof |
| IL310662A (en) | 2021-08-23 | 2024-04-01 | Immunitas Therapeutics Inc | Anti-CD161 antibodies and their uses |
| WO2023069421A1 (en) | 2021-10-18 | 2023-04-27 | Byomass Inc. | Anti-activin a antibodies, compositions and uses thereof |
| WO2023081898A1 (en) | 2021-11-08 | 2023-05-11 | Alector Llc | Soluble cd33 as a biomarker for anti-cd33 efficacy |
| WO2023102077A1 (en) | 2021-12-01 | 2023-06-08 | Sutro Biopharma, Inc. | Anti-folate receptor conjugate cancer therapy |
| WO2023104904A2 (en) | 2021-12-08 | 2023-06-15 | Genclis | The sars-cov-2 and variants use two independent cell receptors to replicate |
| WO2023122213A1 (en) | 2021-12-22 | 2023-06-29 | Byomass Inc. | Targeting gdf15-gfral pathway cross-reference to related applications |
| WO2023147107A1 (en) | 2022-01-31 | 2023-08-03 | Byomass Inc. | Myeloproliferative conditions |
| WO2023164516A1 (en) | 2022-02-23 | 2023-08-31 | Alector Llc | Methods of use of anti-trem2 antibodies |
| WO2023178192A1 (en) | 2022-03-15 | 2023-09-21 | Compugen Ltd. | Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer |
| WO2023192976A1 (en) | 2022-04-01 | 2023-10-05 | Board Of Regents, The University Of Texas System | Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor |
| WO2023209177A1 (en) | 2022-04-29 | 2023-11-02 | Astrazeneca Uk Limited | Sars-cov-2 antibodies and methods of using the same |
Family Cites Families (220)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230685A (en) | 1979-02-28 | 1980-10-28 | Northwestern University | Method of magnetic separation of cells and the like, and microspheres for use therein |
| US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
| US4661454A (en) | 1983-02-28 | 1987-04-28 | Collaborative Research, Inc. | GAL1 yeast promoter linked to non galactokinase gene |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8408127D0 (en) | 1984-03-29 | 1984-05-10 | Nyegaard & Co As | Contrast agents |
| US5118605A (en) * | 1984-10-16 | 1992-06-02 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
| US6492107B1 (en) * | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| DE3546807C2 (pt) * | 1985-03-30 | 1991-03-28 | Marc Genf/Geneve Ch Ballivet | |
| CA1293460C (en) | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
| US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US4770183A (en) | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| DE3785186T2 (de) | 1986-09-02 | 1993-07-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| WO1988006630A1 (en) | 1987-03-02 | 1988-09-07 | Genex Corporation | Method for the preparation of binding molecules |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5688666A (en) * | 1988-10-28 | 1997-11-18 | Genentech, Inc. | Growth hormone variants with altered binding properties |
| EP0368684B2 (en) * | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| ES2067018T3 (es) | 1988-12-28 | 1995-03-16 | Stefan Miltenyi | Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos. |
| US6969586B1 (en) * | 1989-05-16 | 2005-11-29 | Scripps Research Institute | Method for tapping the immunological repertoire |
| US6291159B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291160B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291158B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| US6680192B1 (en) * | 1989-05-16 | 2004-01-20 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291161B1 (en) * | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| DE4002897A1 (de) * | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
| ATE449853T1 (de) * | 1990-02-01 | 2009-12-15 | Siemens Healthcare Diagnostics | HERSTELLUNG UND VERWENDUNG VON GENBANKEN MENSCHLICHER ANTIKÖRPER(ßHUMAN-ANTIKÖRPER- BIBLIOTHEKENß) |
| JP4251406B2 (ja) | 1990-04-05 | 2009-04-08 | クレア，ロベルト | ウォーク―スルー突然変異誘発 |
| ATE167520T1 (de) * | 1990-04-18 | 1998-07-15 | Gist Brocades Nv | Mutierte beta-lactamacylasegene |
| US7063943B1 (en) * | 1990-07-10 | 2006-06-20 | Cambridge Antibody Technology | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) * | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6916605B1 (en) * | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| GB9206318D0 (en) * | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| US6172197B1 (en) * | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5780279A (en) * | 1990-12-03 | 1998-07-14 | Genentech, Inc. | Method of selection of proteolytic cleavage sites by directed evolution and phagemid display |
| ES2113940T3 (es) * | 1990-12-03 | 1998-05-16 | Genentech Inc | Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas. |
| EP0580737B1 (en) * | 1991-04-10 | 2004-06-16 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
| US6072039A (en) | 1991-04-19 | 2000-06-06 | Rohm And Haas Company | Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| US5858657A (en) * | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| DE69230142T2 (de) * | 1991-05-15 | 2000-03-09 | Cambridge Antibody Tech | Verfahren zur herstellung von spezifischen bindungspaargliedern |
| US6225447B1 (en) * | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| US5962255A (en) * | 1992-03-24 | 1999-10-05 | Cambridge Antibody Technology Limited | Methods for producing recombinant vectors |
| US6492160B1 (en) * | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| WO1993003151A1 (en) * | 1991-08-10 | 1993-02-18 | Medical Research Council | Treatment of cell populations |
| ES2136092T3 (es) * | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| DE69216385T2 (de) | 1991-10-11 | 1997-06-12 | Promega Corp | Gekoppelte transkription und translation in zellfreien eukaryoten-extrakten |
| US5492817A (en) | 1993-11-09 | 1996-02-20 | Promega Corporation | Coupled transcription and translation in eukaryotic cell-free extract |
| US5665563A (en) | 1991-10-11 | 1997-09-09 | Promega Corporation | Coupled transcription and translation in eukaryotic cell-free extract |
| US5866344A (en) | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| US20030036092A1 (en) | 1991-11-15 | 2003-02-20 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| WO1993011236A1 (en) * | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| US5872215A (en) * | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
| US5667988A (en) * | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US5733743A (en) * | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| KR950702634A (ko) | 1992-07-08 | 1995-07-29 | 이. 아디에 | 융합 단백질을 생성시킴으로써 미생물 세포의 세포벽에 효소를 고정화시키는 방법(Process for Immobilizing Enzymes to the Cell Wall of a Microbial Cell by Producing a Fusion Protein) |
| CA2137558A1 (en) | 1992-07-17 | 1994-02-03 | Wayne A. Marasco | Method of intracellular binding of target molecules |
| CA2145757A1 (en) | 1992-09-30 | 1994-04-14 | Dennis R. Burton | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| US7166423B1 (en) | 1992-10-21 | 2007-01-23 | Miltenyi Biotec Gmbh | Direct selection of cells by secretion product |
| DE4237113B4 (de) | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
| GB9225453D0 (en) * | 1992-12-04 | 1993-01-27 | Medical Res Council | Binding proteins |
| JP3720353B2 (ja) * | 1992-12-04 | 2005-11-24 | メディカル リサーチ カウンシル | 多価および多重特異性の結合タンパク質、それらの製造および使用 |
| ES2199959T3 (es) * | 1993-02-04 | 2004-03-01 | Borean Pharma A/S | Procedimiento mejorado para el replegamiento de proteinas. |
| DK0682710T3 (da) | 1993-02-10 | 2004-03-01 | Unilever Nv | Isolationsmetode, ved hvilken der anvendes immobiliserede proteiner med specifikke kapaciteter |
| GB9313509D0 (en) * | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
| AU7516694A (en) | 1993-07-30 | 1995-02-28 | Affymax Technologies N.V. | Biotinylation of proteins |
| EP0720624B1 (en) * | 1993-09-22 | 1998-11-25 | Medical Research Council | Retargeting antibodies |
| US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5525490A (en) | 1994-03-29 | 1996-06-11 | Onyx Pharmaceuticals, Inc. | Reverse two-hybrid method |
| US5695941A (en) | 1994-06-22 | 1997-12-09 | The General Hospital Corporation | Interaction trap systems for analysis of protein networks |
| CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
| GB9414506D0 (en) * | 1994-07-18 | 1994-09-07 | Zeneca Ltd | Improved production of polyhydroxyalkanoate |
| US5888773A (en) | 1994-08-17 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Method of producing single-chain Fv molecules |
| US5763733A (en) | 1994-10-13 | 1998-06-09 | Enzon, Inc. | Antigen-binding fusion proteins |
| GB9504344D0 (en) | 1995-03-03 | 1995-04-19 | Unilever Plc | Antibody fragment production |
| DE69636866D1 (en) | 1995-04-11 | 2007-03-15 | Gen Hospital Corp | Reverse "two-hybrid"-systeme |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| US6706484B1 (en) * | 1995-08-18 | 2004-03-16 | Morphosys Ag | Protein/(poly)peptide libraries |
| FR2741892B1 (fr) | 1995-12-04 | 1998-02-13 | Pasteur Merieux Serums Vacc | Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus |
| DE19637718A1 (de) | 1996-04-01 | 1997-10-02 | Boehringer Mannheim Gmbh | Rekombinante inaktive Core-Streptavidin Mutanten |
| WO1997041255A1 (en) | 1996-04-26 | 1997-11-06 | Massachusetts Institute Of Technology | Three-hybrid screening assay |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6699658B1 (en) | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6300065B1 (en) | 1996-05-31 | 2001-10-09 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6083693A (en) | 1996-06-14 | 2000-07-04 | Curagen Corporation | Identification and comparison of protein-protein interactions that occur in populations |
| DE19624562A1 (de) | 1996-06-20 | 1998-01-02 | Thomas Dr Koehler | Verfahren zur Bestimmung von Konzentrationsverhältnissen zweier sich um mindestens ein Nucleotid unterscheidender Nucleinsäuren und Testkit zur Durchführung des Verfahrens |
| CZ296807B6 (cs) | 1996-06-24 | 2006-06-14 | Zlb Behring Ag | Polypeptidy schopné tvorby vazebných struktur proantigen se specificitou pro Rhesus D antigeny, DNA kódující takové polypeptidy a zpusob jejich prípravy a pouzití |
| US5994515A (en) | 1996-06-25 | 1999-11-30 | Trustees Of The University Of Pennsylvania | Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
| GB9712818D0 (en) * | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
| US5948620A (en) | 1996-08-05 | 1999-09-07 | Amersham International Plc | Reverse two-hybrid system employing post-translation signal modulation |
| US5955275A (en) | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| ATE284972T1 (de) | 1996-09-24 | 2005-01-15 | Cadus Pharmaceutical Corp | Verfahren und zusammensetzungen für die identifizierung von receptor effectoren |
| DE19641876B4 (de) | 1996-10-10 | 2011-09-29 | Iba Gmbh | Streptavidinmuteine |
| US6255455B1 (en) | 1996-10-11 | 2001-07-03 | The Trustees Of The University Of Pennsylvania | Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
| US5858671A (en) * | 1996-11-01 | 1999-01-12 | The University Of Iowa Research Foundation | Iterative and regenerative DNA sequencing method |
| US5869250A (en) | 1996-12-02 | 1999-02-09 | The University Of North Carolina At Chapel Hill | Method for the identification of peptides that recognize specific DNA sequences |
| US6261804B1 (en) | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
| DE69835143T2 (de) | 1997-01-21 | 2007-06-06 | The General Hospital Corp., Boston | Selektion von proteinen mittels rns-protein fusionen |
| WO1998040396A1 (en) | 1997-03-14 | 1998-09-17 | Trustees Of Boston University | Multiflavor streptavidin |
| AU8755798A (en) * | 1997-04-04 | 1998-11-13 | Biosite Diagnostics Incorporated | Polyvalent and polyclonal libraries |
| US6057098A (en) * | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| WO1998048008A1 (en) | 1997-04-23 | 1998-10-29 | Plueckthun Andreas | Methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules |
| CA2288994C (en) | 1997-04-30 | 2011-07-05 | Enzon, Inc. | Polyalkylene oxide-modified single chain polypeptides |
| AU736549B2 (en) | 1997-05-21 | 2001-08-02 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Method for the production of non-immunogenic proteins |
| WO1999006834A2 (en) | 1997-08-04 | 1999-02-11 | Ixsys, Incorporated | Methods for identifying ligand specific binding molecules |
| US6391311B1 (en) | 1998-03-17 | 2002-05-21 | Genentech, Inc. | Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1 |
| GB9722131D0 (en) * | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| EP1036329A1 (en) | 1997-11-27 | 2000-09-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Identification and characterization of interacting molecules using automation |
| AU3587599A (en) | 1997-11-28 | 1999-06-16 | Invitrogen Corporation | Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo |
| US6759243B2 (en) | 1998-01-20 | 2004-07-06 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
| WO1999039744A1 (en) | 1998-02-10 | 1999-08-12 | The Ohio State University Research Foundation | Compositions and methods for polynucleotide delivery |
| US6187535B1 (en) | 1998-02-18 | 2001-02-13 | Institut Pasteur | Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides |
| JP4786793B2 (ja) | 1998-03-30 | 2011-10-05 | ノースウエスト バイオセラピューティクス，インコーポレイティド | 腫瘍形成におけるｃｘｃｒ−４遺伝子の役割に基く治療的および診断的応用 |
| US20020029391A1 (en) | 1998-04-15 | 2002-03-07 | Claude Geoffrey Davis | Epitope-driven human antibody production and gene expression profiling |
| US7244826B1 (en) | 1998-04-24 | 2007-07-17 | The Regents Of The University Of California | Internalizing ERB2 antibodies |
| WO2000018905A1 (en) | 1998-09-25 | 2000-04-06 | G.D. Searle & Co. | Method of producing permuteins by scanning permutagenesis |
| GB2344886B (en) | 1999-03-10 | 2000-11-01 | Medical Res Council | Selection of intracellular immunoglobulins |
| US6531580B1 (en) * | 1999-06-24 | 2003-03-11 | Ixsys, Inc. | Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
| DK1144607T5 (da) * | 1999-07-20 | 2009-10-05 | Morphosys Ag | Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger |
| US6171795B1 (en) | 1999-07-29 | 2001-01-09 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to CD40ligand |
| WO2001023619A1 (en) | 1999-09-29 | 2001-04-05 | Xenoport, Inc. | Compounds displayed on replicable genetic packages and methods of using same |
| US7037706B1 (en) | 1999-09-29 | 2006-05-02 | Xenoport, Inc. | Compounds displayed on replicable genetic packages and methods of using same |
| AU2001253521A1 (en) | 2000-04-13 | 2001-10-30 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the cxcr4 gene |
| US8288322B2 (en) * | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| CA2406236C (en) | 2000-04-17 | 2013-02-19 | Dyax Corp. | Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| US6358733B1 (en) | 2000-05-19 | 2002-03-19 | Apolife, Inc. | Expression of heterologous multi-domain proteins in yeast |
| US20050158838A1 (en) * | 2000-06-19 | 2005-07-21 | Dyax Corp., A Delaware Corporation | Novel enterokinase cleavage sequences |
| US6410271B1 (en) | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Generation of highly diverse library of expression vectors via homologous recombination in yeast |
| US6406863B1 (en) | 2000-06-23 | 2002-06-18 | Genetastix Corporation | High throughput generation and screening of fully human antibody repertoire in yeast |
| US6410246B1 (en) | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Highly diverse library of yeast expression vectors |
| WO2002006464A2 (en) | 2000-07-13 | 2002-01-24 | The Curators Of The University Of Missouri | Large scale expression and purification of recombinant proteins |
| US6512263B1 (en) | 2000-09-22 | 2003-01-28 | Sandisk Corporation | Non-volatile memory cell array having discontinuous source and drain diffusions contacted by continuous bit line conductors and methods of forming |
| AU2002211647A1 (en) | 2000-10-12 | 2002-04-22 | University Of Georgia Research Foundation, Inc. | Metal binding proteins, recombinant host cells and methods |
| US7094571B2 (en) | 2000-10-27 | 2006-08-22 | The Board Of Regents Of The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
| US7083945B1 (en) | 2000-10-27 | 2006-08-01 | The Board Of Regents Of The University Of Texas System | Isolation of binding proteins with high affinity to ligands |
| US7138496B2 (en) | 2002-02-08 | 2006-11-21 | Genetastix Corporation | Human monoclonal antibodies against human CXCR4 |
| US6610472B1 (en) | 2000-10-31 | 2003-08-26 | Genetastix Corporation | Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| US20030165988A1 (en) | 2002-02-08 | 2003-09-04 | Shaobing Hua | High throughput generation of human monoclonal antibody against peptide fragments derived from membrane proteins |
| US7005503B2 (en) | 2002-02-08 | 2006-02-28 | Genetastix Corporation | Human monoclonal antibody against coreceptors for human immunodeficiency virus |
| US6841359B2 (en) | 2000-10-31 | 2005-01-11 | The General Hospital Corporation | Streptavidin-binding peptides and uses thereof |
| DK2316940T3 (da) * | 2000-12-18 | 2013-11-04 | Dyax Corp | Fokuserede biblioteker af genpakker |
| EP1227321A1 (en) | 2000-12-28 | 2002-07-31 | Institut für Bioanalytik GmbH | Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| US20020197691A1 (en) | 2001-04-30 | 2002-12-26 | Myriad Genetics, Incorporated | FLT4-interacting proteins and use thereof |
| ATE325865T1 (de) | 2001-01-16 | 2006-06-15 | Regeneron Pharma | Isolierung von sezernierte proteine exprimierenden zellen |
| DE10113776B4 (de) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins |
| EP1385984A4 (en) | 2001-03-21 | 2007-06-13 | Xenoport Inc | COMPOUND PRESENTED ON AN ICOSAEDRIC PHAGE AND METHOD OF USE THEREOF |
| JP2004532024A (ja) | 2001-04-05 | 2004-10-21 | ネクストジェン サイエンスズ リミティド | タンパク質解析 |
| JP4234999B2 (ja) | 2001-04-06 | 2009-03-04 | トマス ジェファソン ユニバーシティ | 治療標的としてのｈｉｖ−１ｖｉｆタンパク質の多量体形成 |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| DE60236861D1 (de) | 2001-04-26 | 2010-08-12 | Amgen Mountain View Inc | Kombinatorische bibliotheken von monomerdomänen |
| US20050048512A1 (en) | 2001-04-26 | 2005-03-03 | Avidia Research Institute | Combinatorial libraries of monomer domains |
| US20040175756A1 (en) | 2001-04-26 | 2004-09-09 | Avidia Research Institute | Methods for using combinatorial libraries of monomer domains |
| US20050089932A1 (en) | 2001-04-26 | 2005-04-28 | Avidia Research Institute | Novel proteins with targeted binding |
| DE10129815A1 (de) | 2001-06-24 | 2003-01-09 | Profos Ag | Verfahren zur Aufreinigung von Bakterienzellen und Zellbestandteilen |
| GB0118337D0 (en) | 2001-07-27 | 2001-09-19 | Lonza Biologics Plc | Method for selecting antibody expressing cells |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
| EP1433793A4 (en) | 2001-09-13 | 2006-01-25 | Inst Antibodies Co Ltd | METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY |
| ATE524484T1 (de) | 2001-09-25 | 2011-09-15 | Hoffmann La Roche | In vitro verfahren zur sequenzspezifischen biotinylierung von polypeptiden |
| WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| AU2001298053A1 (en) | 2001-09-27 | 2003-04-14 | Pieris Proteolab Ag | Muteins of apolipoprotein D |
| CA2462113C (en) | 2001-10-01 | 2013-01-29 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| DE10230147A1 (de) | 2001-10-09 | 2004-01-15 | Profos Ag | Verfahren zur unspezifischen Anreicherung von Bakterienzellen |
| DE10230997A1 (de) * | 2001-10-26 | 2003-07-17 | Ribopharma Ag | Medikament zur Erhöhung der Wirksamkeit eines Rezeptor-vermittelt Apoptose in Tumorzellen auslösenden Arzneimittels |
| US7985553B2 (en) | 2001-10-29 | 2011-07-26 | Nathaniel Heintz | Method for isolating cell type-specific mRNAs |
| DE50307984D1 (de) | 2002-03-01 | 2007-09-27 | Volker A Erdmann | Streptavidin-Bindungspeptid |
| US8524862B2 (en) | 2002-03-19 | 2013-09-03 | Cincinnati Children's Hospital Medical Center | Muteins of C5a anaphylatoxin and methods of inhibiting C5a |
| CN1653335A (zh) * | 2002-04-17 | 2005-08-10 | 罗伯特欧·克瑞 | 免疫球蛋白通用文库 |
| WO2003106639A2 (en) | 2002-06-14 | 2003-12-24 | Dyax Corporation | Recombination of nucleic acid library members |
| JP4659453B2 (ja) | 2002-06-24 | 2011-03-30 | ハイグロス・インヴェスト・ゲゼルシャフト・ミット・ベシュレンクトル・ハフツング | エンドトキシンを検出および除去する方法 |
| WO2004015083A2 (en) | 2002-08-08 | 2004-02-19 | Insert Therapeutics, Inc. | Compositions and uses of motor protein-binding moieties |
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| JP2006500035A (ja) | 2002-09-23 | 2006-01-05 | マクロジェニックス インコーポレイテッド | ヘルペスウイルス科の核酸配列および／またはポリペプチド配列を含むワクチンの同定方法およびワクチン接種用組成物 |
| US20050058661A1 (en) | 2002-10-18 | 2005-03-17 | Sykes Kathryn F. | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia |
| JP2006524039A (ja) | 2003-01-09 | 2006-10-26 | マクロジェニクス，インコーポレーテッド | 変異型Ｆｃ領域を含む抗体の同定および作製ならびにその利用法 |
| CA2513025A1 (en) | 2003-01-09 | 2004-07-29 | Macrogenics, Inc. | Dual expression vector system for antibody expression in bacterial and mammalian cells |
| US20050233389A1 (en) | 2003-01-09 | 2005-10-20 | Massachusetts Institute Of Technology | Methods and compositions for peptide and protein labeling |
| US7172877B2 (en) | 2003-01-09 | 2007-02-06 | Massachusetts Institute Of Technology | Methods and compositions for peptide and protein labeling |
| EP1452601A1 (en) | 2003-02-28 | 2004-09-01 | Roche Diagnostics GmbH | Enhanced expression of fusion polypeptides with a biotinylation tag |
| EP1454981A1 (en) | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infectious pestivirus pseudo-particles containing functional erns, E1, E2 envelope proteins |
| US20060024676A1 (en) | 2003-04-14 | 2006-02-02 | Karen Uhlmann | Method of detecting epigenetic biomarkers by quantitative methyISNP analysis |
| CN1813059A (zh) | 2003-05-02 | 2006-08-02 | 西格玛-奥尔德利希公司 | 固相细胞裂解和捕获平台 |
| WO2004101790A1 (en) * | 2003-05-14 | 2004-11-25 | Domantis Limited | A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| US20050048545A1 (en) | 2003-07-10 | 2005-03-03 | Cull Millard Gambrell | Universal detection of binding |
| US7569215B2 (en) | 2003-07-18 | 2009-08-04 | Massachusetts Institute Of Technology | Mutant interleukin-2 (IL-2) polypeptides |
| EP1503161A3 (en) | 2003-08-01 | 2006-08-09 | Asahi Glass Company Ltd. | Firing container for silicon nitride ceramics |
| DK1664343T3 (da) | 2003-09-09 | 2014-08-11 | Integrigen Inc | Fremgangsmåder og sammensætninger til generering af kimcelle humane antistofgener |
| WO2005040229A2 (en) | 2003-10-24 | 2005-05-06 | Avidia, Inc. | Ldl receptor class a and egf domain monomers and multimers |
| EP2221315A1 (en) | 2003-12-04 | 2010-08-25 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
| US20050191710A1 (en) | 2004-03-01 | 2005-09-01 | Hanrahan John W. | Method for labeling a membrane-localized protein |
| WO2006026248A1 (en) | 2004-08-25 | 2006-03-09 | Sigma-Aldrich Co. | Compositions and methods employing zwitterionic detergent combinations |
| AU2005296200B2 (en) | 2004-09-17 | 2011-07-14 | Pacific Biosciences Of California, Inc. | Apparatus and method for analysis of molecules |
| CA2591992A1 (en) | 2004-12-22 | 2006-06-29 | The Salk Institute For Biological Studies | Compositions and methods for producing recombinant proteins |
| US8551920B2 (en) * | 2005-02-01 | 2013-10-08 | Morpho Sys AG | Libraries and methods for isolating antibodies |
| DK1844074T3 (da) | 2005-02-03 | 2013-07-15 | Antitope Ltd | Humane antistoffer og proteiner |
| US20070141548A1 (en) | 2005-03-11 | 2007-06-21 | Jorg Kohl | Organ transplant solutions and method for transplanting organs |
| JP2008546392A (ja) | 2005-06-17 | 2008-12-25 | バイオレクシス ファーマシューティカル コーポレーション | 固定されたトランスフェリン融合タンパク質ライブラリー |
| WO2007056441A2 (en) * | 2005-11-07 | 2007-05-18 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| AU2006338198B2 (en) * | 2005-12-02 | 2012-04-26 | Genentech, Inc. | Binding polypeptides and uses thereof |
| CN101389655B (zh) | 2005-12-20 | 2013-05-22 | 莫佛塞斯公司 | 新的hcdr3区域集合及其应用 |
| US20070275416A1 (en) | 2006-05-16 | 2007-11-29 | Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh | Affinity marker for purification of proteins |
| US20080171059A1 (en) | 2006-08-07 | 2008-07-17 | Shanshan Wu Howland | Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens |
| US8807164B2 (en) | 2006-08-30 | 2014-08-19 | Semba Biosciences, Inc. | Valve module and methods for simulated moving bed chromatography |
| US7806137B2 (en) | 2006-08-30 | 2010-10-05 | Semba Biosciences, Inc. | Control system for simulated moving bed chromatography |
| US7790040B2 (en) | 2006-08-30 | 2010-09-07 | Semba Biosciences, Inc. | Continuous isocratic affinity chromatography |
| EP2069558B1 (en) * | 2006-10-02 | 2013-05-01 | Sea Lane Biotechnologies,llc. | Design and construction of diverse synthetic peptide and polypeptide libraries |
| US8067179B2 (en) | 2006-11-30 | 2011-11-29 | Research Development Foundation | Immunoglobulin libraries |
| EP2129396B1 (en) | 2007-02-16 | 2013-08-21 | Merrimack Pharmaceuticals, Inc. | Antibodies against erbb3 and uses thereof |
| MX344415B (es) | 2007-09-14 | 2016-12-15 | Adimab Inc | Bancos de anticuerpos sinteticos, designados racionalmente y usos para los mismos. |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
| JP5677972B2 (ja) | 2008-11-18 | 2015-02-25 | メリマック ファーマシューティカルズ インコーポレーティッド | ヒト血清アルブミンリンカーおよびそのコンジュゲート |
| JP2013504602A (ja) * | 2009-09-14 | 2013-02-07 | ダイアックス コーポレーション | 新しく設計したｈｃｃｄｒ３を含む遺伝子パッケージライブラリー |
| WO2011035205A2 (en) | 2009-09-18 | 2011-03-24 | Calmune Corporation | Antibodies against candida, collections thereof and methods of use |
| US9051375B2 (en) | 2010-12-21 | 2015-06-09 | The University Of Western Ontario | Alkali-resistant variants of protein A and their use in affinity chromatography |
| US20140080766A1 (en) | 2011-01-07 | 2014-03-20 | Massachusetts Institute Of Technology | Compositions and methods for macromolecular drug delivery |
| SG10201604554WA (en) | 2011-06-08 | 2016-07-28 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
-
2008
- 2008-09-12 MX MX2013010158A patent/MX344415B/es unknown
- 2008-09-12 JP JP2010525049A patent/JP5933894B2/ja active Active
- 2008-09-12 CA CA3187687A patent/CA3187687A1/en active Pending
- 2008-09-12 CA CA2964398A patent/CA2964398C/en active Active
- 2008-09-12 MX MX2010002661A patent/MX2010002661A/es active IP Right Grant
- 2008-09-12 US US12/210,072 patent/US8691730B2/en active Active
- 2008-09-12 BR BRPI0816785A patent/BRPI0816785A2/pt not_active Application Discontinuation
- 2008-09-12 EP EP20161796.6A patent/EP3753947A1/en active Pending
- 2008-09-12 CA CA2697193A patent/CA2697193C/en active Active
- 2008-09-12 CN CN200880116593.0A patent/CN101855242B/zh active Active
- 2008-09-12 AU AU2008298603A patent/AU2008298603B2/en active Active
- 2008-09-12 DK DK16169483.1T patent/DK3124497T3/da active
- 2008-09-12 EP EP16169483.1A patent/EP3124497B1/en active Active
- 2008-09-12 EP EP08830652.7A patent/EP2193146B1/en active Active
- 2008-09-12 WO PCT/US2008/076300 patent/WO2009036379A2/en active Application Filing
-
2010
- 2010-03-09 MX MX2021006269A patent/MX2021006269A/es unknown
-
2011
- 2011-02-15 HK HK11101445.6A patent/HK1147271A1/xx unknown
-
2014
- 2014-01-08 US US14/150,129 patent/US10189894B2/en active Active
- 2014-10-30 JP JP2014220988A patent/JP6383640B2/ja active Active
-
2016
- 2016-05-06 JP JP2016092989A patent/JP6434447B2/ja active Active
-
2017
- 2017-11-02 JP JP2017212474A patent/JP6685267B2/ja active Active
-
2018
- 2018-12-10 US US16/215,523 patent/US11008383B2/en active Active
-
2020
- 2020-03-31 JP JP2020062671A patent/JP6997246B2/ja active Active
-
2021
- 2021-12-16 JP JP2021204097A patent/JP2022040137A/ja not_active Withdrawn
-
2023
- 2023-08-30 US US17/856,673 patent/US20230399386A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0816785A2 (pt) | bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas | |
| CY2019004I1 (el) | Τροποποιημενα αντισωματα αντι-ιl-23ρ19 | |
| BRPI0717638A2 (pt) | Anticorpors e imunoconjugados e usos para os mesmos | |
| BRPI0821276A2 (pt) | Produto, e, uso do produto | |
| BRPI0715917A2 (pt) | Anticorpos para il-17a | |
| BRPI0819909A2 (pt) | anticorpos antimesotelina e usos dos mesmos | |
| BRPI0817677A2 (pt) | Pó para bebida instantânea | |
| BRPI0818373A2 (pt) | compostos de pelicetal, síntese e aplicações | |
| BRPI0923159A2 (pt) | gene de delta-endotoxina axmi-150 e métodos para sua utilização. | |
| BRPI0807473A2 (pt) | Recipiente, javre e conjunto de recipiente e javre | |
| CR10705A (es) | Anticuerpos para linfotoxina-alfa | |
| BRPI0806964A2 (pt) | Combinações de agonístico beta-2-adrenoceptor e benzotiazolona | |
| BRPI0822296A2 (pt) | Transponder e livreto | |
| DE112008002590A5 (de) | Mikroreaktor | |
| BRPI0810701A2 (pt) | Catalisadores | |
| DE602007013849D1 (de) | Mikroreaktor | |
| BRPI0809684A2 (pt) | Embalagem, e embalagem | |
| BRPI0913351A2 (pt) | sistema para lavagem de tecidos à mão | |
| BRPI0813187A2 (pt) | 13-hidroperóxido liases modificadas e respectivos usos. | |
| ES1060653Y (es) | Estructura de cerramiento para la construccion. | |
| ES1060081Y (es) | Pieza para construccion. | |
| BRPI0810009A2 (pt) | Composto, composição farmacêutica, e, intermediário sintético | |
| ES1060125Y (es) | Peana para parasoles. | |
| UY3788Q (es) | Botella para perfume | |
| ES1063731Y (es) | Soporte de sustentacion para monolitos y similares. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ADIMAB, LLC (US) |
|
| B25G | Requested change of headquarter approved |
Owner name: ADIMAB, LLC (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |